Action never stops at Cooper! Tudor G. Jovin, MD Hamza Shaikh, MD Ajith J. Thomas, MD Jane Khalife

Another fantastic collab between Cooper Medical School of Rowan University and Cooper University Health Care Cooper Neurology Residency #stroke team! With Jesse Thon Max Roland Terri Yeager Nick Vigilante scottk224 Mark Heslin linda zhang • 章文琳 Pratit and others 👇🏽 authors.elsevier.com/a/1ej2R3lH44mK…

Join Fawaz Al-Mufti, MD, FSVIN and myself moderating the 2022 @AANMember-SVIN joint mentoring session on Monday April 25 at 4 pm EST with speakers: Robin N Thanh Nguyen 🇺🇦 Ameer E. Hassan Dileep R. Yavagal AshuJadhav @SantiagoOrtegaMD Register at: us06web.zoom.us/webinar/regist…

Stroke: Vascular and Interventional Neurology ahajournals.org/toc/svin/2/3

The final clinical trial presentation at this year's European Stroke Org conference sees Tudor G. Jovin, MD deliver results from the BAOCHE study. These results are similar to those from ATTENTION and further support #EVT use in basilar artery occlusion, he notes #ESOC2022 European Stroke Org

Honored to present results of #BAOCHE on behalf of BAOCHE investigators @ESOC’22 today. 212 BA occlusion pts, randomized within 6-24 to Solitaire AB vs BMT. No large core on CT/MRI. EVT beneficial w NNT of 4.5. We now have evidence supporting EVT for BA occlusion up to 24 hrs !!

🗓 Don't miss @AANMember “Stroke/Vascular Neurology Section Meeting" at 2PM CST MAY 24 Section Chair AshuJadhav TOPICS TO BE DISCUSSED ✅Converting from TPA➡️TNK 🚑Mobile Stroke Units 📺Telestroke 🔺Clinical Trial Enrollment Register HERE➡ bit.ly/3wsrtj3

Timely publication of our paper during times of national contrast media shortage !! In the early time window, CTP based selection for thrombectomy does not yield better clinical outcomes or stronger benefit over medical therapy alone compared with no CTP. ahajournals.org/doi/10.1161/ST…

Our chair and fearless leader Tudor G. Jovin, MD concluding the day of the #stroke symposium by debating stenting versus endarterectomy for carotid disease. Thank you to all the speakers and guests for making this program such a success!

ICYMI: Dr. Pratit Patel, a board certified interventional neurologist at the Capital Institute for Neurosciences, discusses some important things to know about brain aneurysms, including symptoms, causes, risk factors, treatments and more. Watch here ⬇️ fb.watch/ehxzL-tLQL/

3/ …and debates by our outstanding clinician leaders ***Direct to CSC for thrombectomy vs PSC first*** Jesse Thon vs. Jim Siegler (@jimsieglermd.bsky.social now) ***Thrombolysis before thrombectomy?*** Tudor G. Jovin, MD vs. Pratit

Another win for the democratization of thrombectomy. MR CLEAN late results just presented at World Stroke Org meeting showed benefit of EVT within 6-24 hrs when patients are selected based on presence of collaterals on CTA, rendering CTP, MRI & perfusion software non-essential.

The most comprehensive & current review of "Direct to Angio" for stroke Shashvat M. Desai AshuJadhav Tudor G. Jovin, MD Marios Psychogios #PoojaKhatri HonorHealth Research Institute BarrowNeurological Cooper Neurology Residency UC Health University of Basel shorturl.at/bIX59

ELAN trial (early vs. delayed initiation of DOACs for post ischemic stroke pts) AshuJadhav Kunakorn Atchaneeyasakul MD MPH Tudor G. Jovin, MD SHAHID NIMJEE Dileep R. Yavagal Pratit European Stroke Org HonorHealth Research Institute BarrowNeurological YoungNIR Results- attached in pics

After 5 years, ARCADIA interim analysis showed no evidence for empiric anticoagulation after ESUS, even in patients with atrial cardiopathy! Pending secondary analysis #ESOC2023 Shashvat M. Desai Jim Siegler (@jimsieglermd.bsky.social now) Matthew Starr AshuJadhav AshuJadhav Tudor G. Jovin, MD

Fantastic talk on Economic Efficiency in enabling stroke thomnectomy by Shashvat M. Desai at ESOC 2023 in Munich 🇩🇪 HonorHealth BarrowNeurological European Stroke Org AshuJadhav Dileep R. Yavagal Kunakorn Atchaneeyasakul MD MPH Gravity Medical Technology Tudor G. Jovin, MD Mouhammad A. Jumaa Mission Thrombectomy Cerebrovascular & Neurointerventional Lab

“Large core is number one excuse for not treating LVO, and should no longer be”— Dr. Tudor Jovin Cooper Neurology Residency Cooper Neurointerventional Surgery Fellowship Tudor G. Jovin, MD

.Fawaz Al-Mufti, MD, FSVIN and Pratit have just introduced an #ISC24 session including several late-breaking oral abstract presentations - the first of which sees Osama Zaidat MD deliver one-year follow-up results from the TESLA Stroke Trial #ISC2024

One of the popular sessions from last year, scheduled again tomorrow at 9:15 am MST. #ISC2024

Equip yourself with knowledge of ARIA, that we are likely to encounter in upcoming years! #ISC2024